PRESS-RELEASE ·Filed Mar 2, 2026

SLDB

Solid Biosciences Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed7mo ago WireGlobeNewswire
Press release: regulatory
Actionable Insight • Neutral

Monitor future insider filings to confirm the executive role of the new hire and assess whether additional inducement grants may follow. Watch for any changes in cash burn or funding needs given the company’s early-stage pipeline.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
SLDB ▲ +17.79% at T+60d
NEUTRAL call ✓ call won +17.79% · α vs SPY +7.47% · entry $5.96 → $7.02
Entry anchored
Mar 2, 03:59 PM ET
via exchange tick
T+1d
+3.02%
call +3.02% · α +2.26%
$6.14
settled 7mo ago
T+5d
+37.25%
call +37.25% · α +37.73%
$8.18
settled 7mo ago
T+20d
+20.81%
call +20.81% · α +25.21%
$7.20
settled 6mo ago
T+60d
+17.79%
call +17.79% · α +7.47%
$7.02
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Solid Biosciences granted 17,600 restricted stock units (RSUs) to a newly hired employee as an inducement for joining the company. The award vests annually over four years and was made under the 2024 Inducement Stock Incentive Plan in compliance with Nasdaq rules.

Key Facts

  • Solid Biosciences granted 17,600 RSUs to a new employee.
  • RSUs vest in four equal annual installments starting from the grant date.
  • The grant was made under the 2024 Inducement Stock Incentive Plan.
  • This issuance complies with Nasdaq Listing Rule 5635(c)(4) for inducement awards.
  • No financial performance metrics, revenue, or earnings data were included in the release.

Financial Impact

Minimal immediate financial impact; potential minor dilution from 17,600 RSUs over four years.

dilutionshare_count

Risk Factors

  • Potential for incremental shareholder dilution as RSUs vest, though current grant is small in magnitude.
  • No near-term commercial revenue; company remains dependent on capital markets for funding.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3247859
11 reports for SLDB
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+20▲ +20.77%Mar 19, 2026
Filters
Rows
Reports for SLDB — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
S-3ASR
NEUTRAL ★ 4/10
$8.39 $10.25▲ +22.17%▲ +22.57%$6.88 (−18.06%)
May 12, 2026
20w ago
Press Release
BEARISH ★ 6/10
$7.38 $7.22▲ +2.17%▲ +1.56%$6.88 (+6.84%)
May 7, 2026
21w ago
Press Release
BULLISH ★ 7/10
$7.07 $6.85▼ −3.11%▼ −6.25%$6.88 (−2.76%)
Apr 23, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$7.92 $6.50▼ −17.93%▼ −21.96%$6.88 (−13.19%)
Apr 10, 2026
24w ago
8-K
NEUTRAL ★ 2/10
$8.39 $7.68▼ −8.46%▼ −16.19%$6.88 (−18.06%)
Apr 1, 2026
26w ago
EFFECT
BEARISH ★ 7/10
$7.38 $7.05▲ +4.47%▲ +14.19%$6.88 (+6.84%)
Mar 19, 2026
28w ago
Press Release
BULLISH ★ 8/10
$7.03 $8.49▲ +20.77%▲ +11.45%$6.88 (−2.20%)
Mar 12, 2026
29w ago
8-K
BULLISH ★ 8/10
$7.71 $8.02▲ +4.02%▲ +2.05%$6.88 (−10.83%)
Mar 11, 2026
29w ago
Press Release
BULLISH ★ 8/10
$7.72 $8.10▲ +4.99%▲ +4.47%$6.88 (−10.89%)
Mar 6, 2026
30w ago
Press Release
NEUTRAL ★ 6/10
$6.75 $7.74▲ +14.67%▲ +16.71%$6.88 (+1.85%)
Showing 10 of 11

US Market Status

Market Open — Closes in 2h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 2, 2026